Uncovering a Glaucoma-Linked Lysophosphatidic Acid-MAPK/AP-1 Fibrosis Axis in Human Trabecular Meshwork Cells and Its Modulation by <i>Diospyros kaki</i> Leaf Extract. [PDF]
Jeon Y +10 more
europepmc +1 more source
Pharmacological Blockade of LPAR1 Does Not Provide Neuroprotection in a Rat Model of Ocular Hypertensive Glaucoma. [PDF]
Kocherlakota S +6 more
europepmc +1 more source
Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential. [PDF]
García-de Soto J +14 more
europepmc +1 more source
Liraglutide attenuates aluminum chloride-induced Alzheimer's disease in rats by modulating the oxLDL/LPA/LPAR1 pathway. [PDF]
Abo El-Magd NF, Ramadan NM, Eraky SM.
europepmc +1 more source
Can a novel lysophosphatidic acid receptor 1 antagonist ACT in time to halt pulmonary fibrosis and improve breathing? [PDF]
Andresen BT.
europepmc +1 more source
Impact of tumor necrosis factor-alpha and lysophosphatidic acid on the behavior of ovarian cancer cells in a three-dimensional collagen hydrogel. [PDF]
Tino AB +3 more
europepmc +1 more source
Lysophosphatidic acid receptor 1 (LPAR1; EDG2; LPA1) [PDF]
openaire +1 more source
Prognostic value of LPAR1 expression and methylation in low-grade gliomas: a meta-analysis of TCGA and CGGA datasets and functional validation. [PDF]
Chen H +8 more
europepmc +1 more source
Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment. [PDF]
HIGUCHI Tomoaki +9 more
core +2 more sources
Lysophosphatidic Acid Regulates Trafficking of β2-Adrenergic Receptors [PDF]
Elena Shumay +3 more
openaire +1 more source

